Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
How To Allocate $5,000 Among 5 Dividend Income And Dividend Growth Stocks And ETFs
09:48am, Thursday, 09'th Feb 2023
In this article, I will show you a portfolio that consists of 5 picks that provide you with Dividend Income and Dividend Growth. When allocating $5,000 between 5 stocks, I would not recommend allocati
Big Pharma's Big Gains
02:14am, Thursday, 09'th Feb 2023
Given enough time, stock in pharmaceutical giants has yielded life-altering gains. Because of its popular and widely distributed COVID-19 vaccine, Pfizer has sparked more controversy than other stocks
The 7 Best Dividend Stocks to Buy for February 2023
10:54am, Wednesday, 08'th Feb 2023
Dividend stocks pay a portion of their earnings to shareholders. Payments are usually made on a regular basis, quarterly, monthly, or annually, and provide a steady stream of income.
Is Eli Lilly Stock a Buy Now?
09:00am, Wednesday, 08'th Feb 2023
There is a lot to like about this drugmaker, but is it enough?
Is Biotech Immunocore About To Make A 25% Price Move?
07:00am, Tuesday, 07'th Feb 2023
The industry is home to some large-cap heavyweights, including Amgen Inc. (NASDAQ: AMGN), Gilead Sciences Inc. (NASDAQ: GILD), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), Vertex Pharmaceuticals Inc
5 Best and Worst Performing Mega-Cap Stocks in January 2023
10:53pm, Friday, 03'rd Feb 2023
The stock market finished January on a positive note. This is a good sign for investors, who incurred huge losses last year.
AbbVie Q4 Preview: What's in Store?
06:49pm, Friday, 03'rd Feb 2023
AbbVie has put in a mixed earnings performance, exceeding bottom line estimates in five consecutive quarters but falling short of sales expectations in each instance.
Lilly (LLY) Reports Q4 Earnings: What Key Metrics Have to Say
08:17am, Friday, 03'rd Feb 2023
While the top- and bottom-line numbers for Lilly (LLY) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare t
Lilly (LLY) Beats on Q4 Earnings, Lags on Sales, Raises '23 View
06:05pm, Thursday, 02'nd Feb 2023
Eli Lilly's (LLY) earnings surpass fourth-quarter estimates while sales slightly miss the mark. The company raises its EPS guidance for 2023.
Merck, Eli Lilly stocks fall over earnings, outlook concerns
03:30pm, Thursday, 02'nd Feb 2023
Senior reporter Anjalee Khemlani joins Yahoo Finance Live to discuss how pharma stocks are faring after reporting earnings.
Pharma earnings: COVID ‘is highly uncertain for this year,' analyst says
02:36pm, Thursday, 02'nd Feb 2023
Pharma Wells Fargo Managing Director Mohit Bansal joins Yahoo Finance Live anchors Rachelle Akuffo and Anjalee Khemlani to discuss pharmaceutical earnings amid COVID uncertainty, the impact of diabeti
Eli Lilly and Company (LLY) Q4 2022 Earnings Call Transcript
02:25pm, Thursday, 02'nd Feb 2023
Eli Lilly and Company (NYSE:LLY ) Q4 2022 Earnings Conference Call February 2, 2023 10:00 AM ET Company Participants Joe Fletcher - Senior Vice President of Investor Relations Dave Ricks - Chairman &
Lilly's ambitious diabetes drug Mounjaro fails to impress in the fourth quarter
01:49pm, Thursday, 02'nd Feb 2023
Eli Lilly's LLY, -5.65% new Type 2 diabetes treatment Mounjaro may be in high demand, but the drug had a wobbly fourth quarter, with sales coming in far below Wall Street's expectations.
Why Eli Lilly Stock Is Under Pressure Today
12:15pm, Thursday, 02'nd Feb 2023
The drugmaker's fourth-quarter earnings failed to impress investors.
